Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Allergy Therapeutics plc AGYTF

Full chart Compare
Set alert

Price alert · AGYTF

All alert types
0.15 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

0.15 Day range 0.15
0.11 52-week range 0.15
YTD
+36.36%
1 year
+36.36%

Financial health

Altman Z-Score

0.16 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -7.4×
FY 2016: -24.1×FY 2017: -104×FY 2018: -29.7×FY 2019: 42.3×FY 2020: 19.2×FY 2021: 57.3×FY 2022: -18.5×FY 2023: -3.7×FY 2024: -4.4×FY 2025: -7.4×
FY 2016 5y median -4.4× FY 2025
P/S 3.9×
FY 2016: 8.7×FY 2017: 5.1×FY 2018: 4.3×FY 2019: 2.5×FY 2020: 2.1×FY 2021: 2.7×FY 2022: 4.3×FY 2023: 3.4×FY 2024: 3.2×FY 2025: 3.9×
FY 2016 5y median 3.4× FY 2025
P/B -7.6×
FY 2016: 13.8×FY 2017: 11.0×FY 2018: 12.7×FY 2019: 4.9×FY 2020: 3.8×FY 2021: 4.8×FY 2022: 8.2×FY 2023: 97.1×FY 2024: 47.9×FY 2025: -7.6×
FY 2016 5y median 8.2× FY 2025
P/FCF -6.7×
FY 2016: -32.1×FY 2017: -212×FY 2018: -49.1×FY 2019: 73.9×FY 2020: 17.7×FY 2021: 39.6×FY 2022: -17.6×FY 2023: -6.0×FY 2024: -5.0×FY 2025: -6.7×
FY 2016 5y median -6.0× FY 2025
EV/EBITDA -8.0×
FY 2016: -37.8×FY 2017: 1623×FY 2018: -61.7×FY 2019: 24.3×FY 2020: 11.4×FY 2021: 24.4×FY 2022: -38.3×FY 2023: -6.3×FY 2024: -6.4×FY 2025: -8.0×
FY 2016 5y median -6.4× FY 2025
EV/Sales 4.5×
FY 2016: 8.2×FY 2017: 4.8×FY 2018: 4.1×FY 2019: 2.2×FY 2020: 1.8×FY 2021: 2.4×FY 2022: 4.1×FY 2023: 3.7×FY 2024: 3.5×FY 2025: 4.5×
FY 2016 5y median 3.7× FY 2025
FCF Yield -14.9%
FY 2016: -3.1%FY 2017: -0.5%FY 2018: -2.0%FY 2019: 1.4%FY 2020: 5.7%FY 2021: 2.5%FY 2022: -5.7%FY 2023: -16.7%FY 2024: -20.0%FY 2025: -14.9%
FY 2016 5y median -14.9% FY 2025

Profitability

Gross Margin 45.7%
FY 2016: 71.0%FY 2017: 73.9%FY 2018: 75.1%FY 2019: 75.1%FY 2020: 74.2%FY 2021: 73.8%FY 2022: 68.0%FY 2023: 55.8%FY 2024: 53.9%FY 2025: 45.7%
FY 2016 5y median 55.8% FY 2025
Operating Margin -37.3%
FY 2016: -24.6%FY 2017: -3.0%FY 2018: -9.8%FY 2019: 6.0%FY 2020: 10.6%FY 2021: 4.8%FY 2022: -16.8%FY 2023: -66.5%FY 2024: -63.9%FY 2025: -37.3%
FY 2016 5y median -37.3% FY 2025
Net Margin -72.9%
FY 2016: -26.9%FY 2017: -3.9%FY 2018: -11.0%FY 2019: 4.7%FY 2020: 9.0%FY 2021: 3.4%FY 2022: -18.9%FY 2023: -72.3%FY 2024: -72.9%FY 2025: -72.9%
FY 2016 5y median -72.3% FY 2025
ROE 142.3%
FY 2016: -43.1%FY 2017: -8.3%FY 2018: -32.7%FY 2019: 9.2%FY 2020: 16.1%FY 2021: 5.9%FY 2022: -36.5%FY 2023: -2084.8%FY 2024: -1084.3%FY 2025: 142.3%
FY 2016 5y median -36.5% FY 2025
ROIC -87.7%
FY 2016: -26.9%FY 2017: -4.4%FY 2018: -18.2%FY 2019: 6.8%FY 2020: 10.3%FY 2021: 4.4%FY 2022: -21.1%FY 2023: -79.3%FY 2024: -76.0%FY 2025: -87.7%
FY 2016 5y median -76.0% FY 2025
ROA -81.6%
FY 2016: -23.1%FY 2017: -4.3%FY 2018: -14.8%FY 2019: 5.1%FY 2020: 8.2%FY 2021: 3.3%FY 2022: -18.7%FY 2023: -64.5%FY 2024: -62.0%FY 2025: -81.6%
FY 2016 5y median -62.0% FY 2025

Growth (YoY)

Revenue 36.9%
FY 2016: 12.2%FY 2017: 32.2%FY 2018: 6.6%FY 2019: 7.9%FY 2020: 6.1%FY 2021: 7.8%FY 2022: -13.7%FY 2023: -18.1%FY 2024: -7.4%FY 2025: 36.9%
FY 2016 FY 2025
Operating Income 20.1%
FY 2016: -1748.4%FY 2017: 84.1%FY 2018: -255.0%FY 2019: 165.2%FY 2020: 89.2%FY 2021: -51.5%FY 2022: -403.8%FY 2023: -223.8%FY 2024: 11.1%FY 2025: 20.1%
FY 2016 FY 2025
EPS (diluted) 21.5%
FY 2016: -14167.4%FY 2017: 82.4%FY 2018: -210.3%FY 2019: 139.9%FY 2020: 93.2%FY 2021: -52.5%FY 2022: -528.6%FY 2023: -213.3%FY 2024: 71.5%FY 2025: 21.5%
FY 2016 FY 2025
Free Cash Flow -23.5%
FY 2016: -1550.7%FY 2017: 88.2%FY 2018: -286.7%FY 2019: 141.8%FY 2020: 278.4%FY 2021: -38.3%FY 2022: -402.3%FY 2023: -90.1%FY 2024: -5.9%FY 2025: -23.5%
FY 2016 FY 2025

Financial Health

Current Ratio 0.9×
FY 2016: 3.0×FY 2017: 2.7×FY 2018: 2.1×FY 2019: 2.8×FY 2020: 3.0×FY 2021: 3.2×FY 2022: 2.4×FY 2023: 1.8×FY 2024: 1.6×FY 2025: 0.9×
FY 2016 5y median 1.8× FY 2025
Quick Ratio 0.6×
FY 2016: 2.4×FY 2017: 2.1×FY 2018: 1.5×FY 2019: 2.2×FY 2020: 2.5×FY 2021: 2.6×FY 2022: 1.7×FY 2023: 1.2×FY 2024: 1.0×FY 2025: 0.6×
FY 2016 5y median 1.2× FY 2025
Debt / Equity -1.6×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.3×FY 2021: 0.2×FY 2022: 0.3×FY 2023: 17.4×FY 2024: 8.4×FY 2025: -1.6×
FY 2016 5y median 0.3× FY 2025
Net Debt / EBITDA -1.0×
FY 2016: 1.9×FY 2017: -98.4×FY 2018: 2.7×FY 2019: -3.8×FY 2020: -2.0×FY 2021: -3.5×FY 2022: 1.3×FY 2023: -0.6×FY 2024: -0.6×FY 2025: -1.0×
FY 2016 5y median -0.6× FY 2025
Interest Coverage -4.2×
FY 2016: -40.8×FY 2017: -8.4×FY 2018: -21.0×FY 2019: 21.8×FY 2020: 16.5×FY 2021: 8.2×FY 2022: -18.3×FY 2023: -16.2×FY 2024: -8.6×FY 2025: -4.2×
FY 2016 5y median -8.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-06-30